Florian Schönharting
Founder en GH RESEARCH PLC .
Fortuna: 262 M $ al 31/03/2024
Origen de la red de primer grado Florian Schönharting.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Private Company | Pharmaceuticals: Major | 12 | |
| Public Company | Pharmaceuticals: Major | 10 | |
Nordic Biotech Advisors ApS
 Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors.
7
| Private Company | Investment Managers | 7 |
GH Research Ireland Ltd.
 GH Research Ireland Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, GH Research Ireland Ltd. is an Irish clinical-stage biopharmaceutical company that develops innovative therapies for the treatment of mental illnesses. The private company is based in Dublin, Ireland and is a subsidiary of GH Research Plc.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Florian Schönharting a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Rosetta Capital I LP | Director/Board Member | ||
Astion Pharma A/S
 Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Astion Pharma A/S develops and manufactures pharmaceutical products. It focuses on developing anti-inflammatory drugs for dermatological and immunological diseases. The company was founded by Morten S. Weidner in 1992 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Cahill Gordon & Reindel LLP
 Cahill Gordon & Reindel LLP Miscellaneous Commercial ServicesCommercial Services Cahill Gordon & Reindel LLP provides legal services. Its practice areas include antitrust, bankruptcy and restructuring, corporate governance and investigations, crisis advisory and management, employee benefits, insurance, intellectual property, litigation, media, real estate, tax, and trusts. The company was founded by Joseph P. Cotton, George S. Franklin, William G. McAdoo and Francis McAdoo in 1919 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Salford | College/University | Graduate Degree | |
Latham & Watkins LLP
 Latham & Watkins LLP Miscellaneous Commercial ServicesCommercial Services Latham & Watkins LLP operates as a full-service law firm or legal matters. It offers services in the areas of finance, litigation, accounting, banking, life sciences, private equity, real estate, government relations, employment law, and outsourcing. The company was founded in 1934 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Boron Molecular Ltd.
 Boron Molecular Ltd. Chemicals: Major DiversifiedProcess Industries Boron Molecular Ltd. manufactures fine chemicals. Its products include biaryls, boronic acid esters and acids, catalyst, cubanes, diborons, energy storage, halides, polymer, raft agents, and trifluoroborates. The company was founded in 2001 and is headquartered in Noble Park, Australia. | Chemicals: Major Diversified | Chief Executive Officer | |
| Georgia State University | College/University | Graduate Degree | |
| INSEAD | College/University | Undergraduate Degree | |
| Copenhagen Business School | College/University | Masters Business Admin Undergraduate Degree | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University College Dublin | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Warwick | College/University | Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| The University of Western Australia | College/University | Doctorate Degree | |
Rosetta Capital Ltd.
 Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital Ltd (Rosetta Capital) is a venture capital firm is founded in 2001 by Jeremy Curnock Cook, Michael Forer and Jonathan Hepple. The firm is headquartered in London. | Investment Managers | Founder Private Equity Investor | |
EyeSense GmbH
 EyeSense GmbH Electronic Equipment/InstrumentsElectronic Technology EyeSense GmbH develops novel ophthalmic self-diagnostic systems for glucose monitoring of diabetes patients. It is developing two different diagnostic systems: An ophthalmic sensor which-once inserted on the eye-can be read out optically as frequently as wanted, without any pain and a continuous sensor, to be worn on the abdomen or upper arm. The firm with its innovative sensor technology able to offer two products that addresses different needs in blood glucose monitoring which are Continuous Glucose Sensor and Eye Sensor. The company was founded in 2006 and is headquartered in Großostheim, Germany. | Electronic Equipment/Instruments | Director/Board Member | |
| University of New England (Australia) | College/University | Masters Business Admin | |
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Biotechnology | Chairman Chief Executive Officer | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Director/Board Member | |
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Biotechnology | Chairman Director/Board Member | |
| Harvard Law School | College/University | Graduate Degree | |
| Kellogg School of Management | College/University | Graduate Degree Doctorate Degree | |
Forward Pharma GmbH
 Forward Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Part of Forward Pharma A/S, Forward Pharma GmbH is a German company that engages in researching and developing biotechnology. The company is based in Leipzig, Germany. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Forward Pharma USA, LLC | Director of Finance/CFO Comptroller/Controller/Auditor | ||
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
| Cytochrome Ltd. | Director/Board Member | ||
| Vistagen Pte Ltd. | Miscellaneous | Director/Board Member | |
Goesch Pharma Pte Ltd.
 Goesch Pharma Pte Ltd. Medical DistributorsDistribution Services Goesch Pharma Pte Ltd. is a Singaporean company that wholesales pharmaceutical products. The private company is based in Singapore, Singapore. | Medical Distributors | Director/Board Member | |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The private company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Pharmaceuticals: Major | Director/Board Member | |
| BIOSERGEN AB | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
| MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 16 |
| Suecia | 9 |
| Dinamarca | 7 |
| Reino Unido | 6 |
| Australia | 4 |
Sectorial
| Health Technology | 24 |
| Consumer Services | 12 |
| Commercial Services | 6 |
| Finance | 4 |
| Process Industries | 2 |
Operativa
| Director/Board Member | 99 |
| Corporate Officer/Principal | 48 |
| Independent Dir/Board Member | 29 |
| Chairman | 21 |
| Chief Executive Officer | 21 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Karen Smith | 29 |
| J. Buchi | 26 |
| Torsten Rüdiger Goesch | 23 |
| Duncan Moore | 19 |
| Michael Forer | 18 |
| Jan van de Winkel | 15 |
| Christian Hansen | 13 |
| Joel D. Sendek | 11 |
| John M. Barberich | 10 |
| Matthew Perry | 10 |
| Spike N. Loy | 9 |
| Julie Ryan | 8 |
| Jakob Mosegaard Larsen | 8 |
| Peder Andersen | 6 |
| Henrik Nilsson | 6 |
- Bolsa de valores
- Insiders
- Florian Schönharting
- Conexiones Empresas
